Sign in
Taking people in United StatesPhase 1/2

Modulating Exercise Dosage to Improve Concussion Recovery

Key facts

Who runs it
University of Colorado, Denver
Where
Aurora, Boston, and Cambridge, United StatesSee the 3 sites
Trial code
Status
Recruiting
Phase
Phase 1/2
People taking part
178 people, planned
Started
5 Aug 2022
Expected to end
1 Feb 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • High Dose Exercise
Record updated
31 August 2026

Who can take part

Age
13 years to 18 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • 13-18 years of age
  • Post-Concussion Symptom Scale (PCSS) score >10 to ensure participants are not recovered by enrollment
  • Concussion diagnosis by a sports medicine physician

Who cannot take part

  • Concussion <6 months before enrollment (excluding the current injury)
  • Pre-existing neurological disorders
  • Exercise contraindications

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 13 and 18 years old?

Where in United States

  • University of Colorado DenverAurora, United StatesContact: David R Howell, PhDTaking people
  • Boston Children's HospitalBoston, United StatesContact: Danielle Hunt, MSTaking people
  • Spaulding Rehabilitation HospitalCambridge, United StatesContact: Andrew Taylor, PhDTaking people

About the trial

What the trial wants to find out

Aerobic exercise has emerged as an effective treatment to reduce sport-related concussion symptom severity, yet existing work lacks rigor regarding the precise exercise volume and intensity required to elicit therapeutic effects, how exercise can alter concussion-related pathophysiology, and whether exercise can prevent the development of secondary sequelae. Our objective is to examine if a high dose exercise program (higher volume than currently prescribed at an individualized, safe intensity level) initiated within 21 days of concussion results in faster symptom resolution, altered physiological function, or reduced secondary sequalae. Findings from this research will lead to more rigorous and precise rehabilitation guidelines and improved understanding about how exercise affects neurophysiological function among adolescents with concussion.

The 2 groups in the trial

  • High Dose ExerciseTreatment being tested

    The investigators will provide exercise dose recommendations for initial visit until symptom resolution, and revise upon symptom resolution (to use for the subsequent 8 weeks). These include intensity (target HR) and volume (frequency/duration). Intensity is calculated as 90% of the HR at the end of the exercise test. The volume recommendation is 150 mins/week (\~30 min/day; 5 days/week). The mode of exercise is another consideration. This will be left to participant preference, so that the investigators do not exclude potential participants due to lack of access to specific exercise equipment.

  • Standard-of-careNo study treatment, for comparison

    Participants are instructed to perform activity in line with physician recommendations. This consists of a general recommendation (no specific HR/volume) or symptom limited physical activity.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Modulating Exercise Dosage to Improve Concussion Recovery: A Randomized Clinical Trial
Criteria questions
Built from NCT05434130, who can take part
Record updated
31 August 2026